The House Energy and Commerce Subcommittee on Consumer Protection and Commerce today held a hearing to examine how pharmaceutical companies are putting “profits over consumers,” highlighting how profits made from drug sales are concentrated around only a few drugs with no competition. “The bottom line is this: drug manufacturers are gaming the system to make more money at consumers’ expense,” said Chairwoman Jan Schakowsky, D-Ill. “And that has to stop.” Witnesses for the hearing were from Rutgers Institute for Information Policy and Law, Emory University School of Law, the Association for Accessible Medicines, and Patients for Affordable Drugs.

Related News Articles

Blog
Tom Nickels, AHA executive vice president, responds to a PhRMA-funded study that attempts to deflect blame for a growing crisis of their own making – the…
Headline
The Centers for Medicare & Medicaid Services today updated its Medicare and Medicaid drug spending dashboards with 2018 data.
Blog
The pharmaceutical industry’s latest “report” is an obvious attempt to divert attention away from a problem of their own making: skyrocketing drug prices.
Headline
Senate Finance Committee leaders Friday released changes to the Prescription Drug Pricing Reduction Act that would eliminate impending Medicaid cuts to…
Blog
The latest report from AIR340B continues to misrepresent a program with a more than 25-year history of helping hospitals stretch scarce financial resources to…
Headline
The AHA today submitted comments to House leaders on the Lower Drug Costs Now Act (H.R. 3), legislation that would make a series of changes to the Medicare…